PL435967A1 - Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnika - Google Patents
Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnikaInfo
- Publication number
- PL435967A1 PL435967A1 PL435967A PL43596720A PL435967A1 PL 435967 A1 PL435967 A1 PL 435967A1 PL 435967 A PL435967 A PL 435967A PL 43596720 A PL43596720 A PL 43596720A PL 435967 A1 PL435967 A1 PL 435967A1
- Authority
- PL
- Poland
- Prior art keywords
- ovarian cancer
- diagnosis
- vitro
- mirna biomarkers
- diagnostic test
- Prior art date
Links
- 206010033128 Ovarian cancer Diseases 0.000 title abstract 12
- 206010061535 Ovarian neoplasm Diseases 0.000 title abstract 12
- 238000000338 in vitro Methods 0.000 title abstract 7
- 238000003745 diagnosis Methods 0.000 title abstract 5
- 239000000090 biomarker Substances 0.000 title abstract 4
- 108091070501 miRNA Proteins 0.000 title abstract 4
- 239000002679 microRNA Substances 0.000 title abstract 4
- 238000002405 diagnostic procedure Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Przedmiotem niniejszego wynalazku jest zestaw biomarkerów miRNA do diagnostyki in vitro raka jajnika, sposób diagnozowania in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA do diagnozowania in vitro raka jajnika, w diagnostycznym badaniu przesiewowym in vitro pod kątem występowania raka jajnika, do oceny skuteczności leczenia raka jajnika, do monitorowania odpowiedzi na leczenie raka jajnika oraz do przewidywania wznowy raka jajnika po ukończonym leczeniu raka jajnika, jak również test do diagnostyki in vitro raka jajnika.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/252,634 US20240002949A1 (en) | 2020-11-12 | 2020-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
PL435967A PL243444B1 (pl) | 2020-11-12 | 2020-11-12 | Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika |
AU2021378868A AU2021378868A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
EP21840201.4A EP4244393A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
CA3198479A CA3198479A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
PCT/PL2021/050079 WO2022103287A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL435967A PL243444B1 (pl) | 2020-11-12 | 2020-11-12 | Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika |
Publications (2)
Publication Number | Publication Date |
---|---|
PL435967A1 true PL435967A1 (pl) | 2022-05-16 |
PL243444B1 PL243444B1 (pl) | 2023-08-28 |
Family
ID=79287850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL435967A PL243444B1 (pl) | 2020-11-12 | 2020-11-12 | Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika |
Country Status (6)
Country | Link |
---|---|
US (1) | US20240002949A1 (pl) |
EP (1) | EP4244393A1 (pl) |
AU (1) | AU2021378868A1 (pl) |
CA (1) | CA3198479A1 (pl) |
PL (1) | PL243444B1 (pl) |
WO (1) | WO2022103287A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024009221A1 (en) * | 2022-07-04 | 2024-01-11 | Artificial Intelligence Expert Srl | Method and system for multi-cancer management in subject |
GB2623570A (en) * | 2022-10-21 | 2024-04-24 | Wobble Genomics Ltd | Method and products for biomarker identification |
CN117838868A (zh) * | 2024-03-04 | 2024-04-09 | 暨南大学 | miR-103-3p在ADSCs移植中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2354246A1 (en) * | 2010-02-05 | 2011-08-10 | febit holding GmbH | miRNA in the diagnosis of ovarian cancer |
US11214839B2 (en) * | 2017-01-09 | 2022-01-04 | Dana-Farber Cancer Institute, Inc. | Circulating microRNA signatures for ovarian cancer |
EP3628736A4 (en) * | 2017-04-28 | 2021-06-09 | Toray Industries, Inc. | KIT, DEVICE AND METHOD FOR DETECTION OF OVARIAL TUMOR |
CN111826466B (zh) * | 2020-07-31 | 2021-06-29 | 南方医科大学深圳医院 | 乙型肝炎感染患者或携带者外泌体miRNA分子标志物组合及筛查试剂盒 |
-
2020
- 2020-11-11 US US18/252,634 patent/US20240002949A1/en active Pending
- 2020-11-12 PL PL435967A patent/PL243444B1/pl unknown
-
2021
- 2021-11-11 CA CA3198479A patent/CA3198479A1/en active Pending
- 2021-11-11 AU AU2021378868A patent/AU2021378868A1/en active Pending
- 2021-11-11 WO PCT/PL2021/050079 patent/WO2022103287A1/en unknown
- 2021-11-11 EP EP21840201.4A patent/EP4244393A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022103287A4 (en) | 2022-07-07 |
PL243444B1 (pl) | 2023-08-28 |
AU2021378868A1 (en) | 2023-06-15 |
EP4244393A1 (en) | 2023-09-20 |
US20240002949A1 (en) | 2024-01-04 |
WO2022103287A1 (en) | 2022-05-19 |
CA3198479A1 (en) | 2022-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL435967A1 (pl) | Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnika | |
MX2018013621A (es) | Metodo, matriz y uso de estos. | |
MX2019008911A (es) | Metodos, matrices y usos de estos. | |
MX2016006125A (es) | Procedimiento, matriz y uso de los mismos. | |
WO2017050939A3 (en) | Method and array for diagnosing pancreatic cancer in an individual | |
MX363201B (es) | Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico. | |
MX2017001302A (es) | Biomarcadores para predecir la respuesta del dlbcl al tratamiento con un inhibidor de la btk. | |
EP2566983A4 (en) | SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE | |
CA2815892C (en) | Analytical methods and arrays for use in the same | |
GB201207297D0 (en) | Analytical methods and arrays for use in the same | |
CL2017001972A1 (es) | Biomarcadores para cáncer pancreático | |
MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
NZ729773A (en) | Biomarkers for disease progression in melanoma | |
WO2015189591A3 (en) | Method and arrays for use in diagnosing early breast cancer | |
EA201492284A1 (ru) | Применение маркеров в диагностике и лечении рака предстательной железы | |
WO2015073896A3 (en) | Biomarkers for psma targeted therapy for prostate cancer | |
BR112016013976A2 (pt) | método para determinar se um indivíduo é afetado por um câncer, método para discriminar entre câncer colorretal e pancreático dentre indivíduos que resultam ser positivos para o método, método para determinar o estágio de um câncer colorretal em um indivíduo afetado e uso de um kit de rt-pcr quantitativo para performar o método | |
BR112018073214A2 (pt) | métodos para a previsão do risco de recorrência da fibrilação atrial, para o diagnóstico de fibrilação atrial em um indivíduo, para o monitoramento de uma terapia e para a classificação da fibrilação e utilizações do biomarcador | |
MX2012007009A (es) | Método para diagnosticar un tumor maligno. | |
WO2015136509A3 (en) | Diagnostic and therapeutic targets for preeclampsia and closely related complications of pregnancy | |
GB201009798D0 (en) | Method,array and use thereof | |
WO2016198833A3 (en) | Methods for analysing a urine sample | |
EP3557259A3 (en) | Methods and arrays for use in the same | |
BR112019001446A2 (pt) | edição de rna como biomarcadores para teste de transtornos de humor | |
Torres et al. | Preliminary psychometric characteristics of the Portuguese version of Patient Health Questionnaire 9 (PHQ-9) in a sample of Portuguese breast cancer women |